Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 56 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

3%

1 of 36 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
45(93.8%)
Phase 4
2(4.2%)
Phase 3
1(2.1%)
48Total
N/A(45)
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (56)

Showing 20 of 56 trials
NCT07853560Not ApplicableNot Yet Recruiting

Study to Investigate Asparagus Racemosus Extract (Shaktiva™) for Psychological Symptoms in Perimenopausal Women

Role: lead

NCT07474831Not ApplicableRecruiting

Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis

Role: lead

NCT07800273Not ApplicableNot Yet Recruiting

Bactorinol® Nasal Spray With Reduced-Dose Mometasone in Adults With Chronic Rhinosinusitis

Role: lead

NCT07562698Not ApplicableCompleted

Ursolic Acid-Standardized Apple Pomace Supplementation for Muscle Strength and Physical Performance in Older Adults With Mild Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Trial

Role: lead

NCT07790549Not ApplicableNot Yet Recruiting

Mirgeal® Gel as Add-on Therapy to Esomeprazole in Adults With Non-Erosive Gastroesophageal Reflux Disease

Role: lead

NCT07789366Not ApplicableNot Yet Recruiting

Berberol P for Mild-to-Moderate Hypercholesterolaemia

Role: lead

NCT07787494Not ApplicableNot Yet Recruiting

Pistacia Lentiscus Oil Nasal Spray With Reduced-Dose Mometasone in Chronic Rhinosinusitis

Role: lead

NCT06370208Not ApplicableCompleted

Prophylactic Effect of Probiotic Streptococcus Salivarius eK12 Against Recurrent Streptococcus Pyogenes Pharyngotonsillitis Infection in Pediatrics

Role: lead

NCT06857565Not ApplicableCompleted

Study to Evaluate the Efficacy of Lactobacillus Crispatus M247 in the Prevention of Recurrent Urinary Tract Infections

Role: lead

NCT07465562Not ApplicableCompleted

Galactol® Enzyme Supplement for Post-Prandial Abdominal Bloating in Irritable Bowel Syndrome

Role: lead

NCT07235826Not ApplicableCompleted

Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children

Role: lead

NCT07234448Not ApplicableCompleted

Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use

Role: lead

NCT07676604Not ApplicableNot Yet Recruiting

Colipral® (Probiotic Strain Escherichia Coli 5C (ECP24®)) for Prevention of Recurrent Cystitis in Menopausal Women

Role: lead

NCT07655219Not ApplicableNot Yet Recruiting

Assessment of the Efficacy of a Highly Standardized Ginger and Perilla Nutraceutical (Dispepril®) in Improving Gastric and Intestinal Symptoms in Patients With Functional Dyspepsia

Role: lead

NCT07198607Completed

Pistacia Lentiscus Oil Nasal Drops for Preventing Recurrence of Chronic Rhinosinusitis

Role: lead

NCT07266688Not ApplicableCompleted

Evaluation of Bactorinol® Nasal Spray in Adult Patients With Vasomotor Rhinitis

Role: lead

NCT06227858Not ApplicableCompleted

Effects of a Standardised Saffron Extract Supplementation on Symptoms Associated With Perimenopause in Healthy Women

Role: lead

NCT07536698Not ApplicableNot Yet Recruiting

Co-supplementation With Bifidobacterium Longum W11 and Colopectin for Maintenance Therapy in Children With Functional Constipation

Role: lead

NCT07519616Not ApplicableNot Yet Recruiting

Effect of Escherichia Coli 5C (Colipral®) on Post-Colonoscopy Gastrointestinal Symptoms

Role: lead

NCT07502807Not ApplicableNot Yet Recruiting

Effect of Neurofast® Supplementation on Anxiety and Cardiovascular Outcomes in the Psycho-Cardio Phenotype Adults

Role: lead